Get started
Author

Sarit Schwartz

Observed name: Schwartz, Sarit
ORCID: 0009-0008-1008-3651
Observed ORCID: 0009-0008-1008-3651
OpenAlex ID: A5106235819
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
2018 · Bob T. Li, Ronglai Shen, et al. · Journal of Clinical Oncology · 579
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
2018 · Gabrielle S. Wong, Jin Zhou, et al. · Nature Medicine · 273
Feedback Suppression of PI3Kα Signaling in PTEN-Mutated Tumors Is Relieved by Selective Inhibition of PI3Kβ
2014 · Sarit Schwartz, John Wongvipat, et al. · Cancer Cell · 253
PDF
An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer
2017 · Yaohua Xue, Luciano Martelotto, et al. · Nature Medicine · 176
Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma
2015 · Oren Litvin, Sarit Schwartz, et al. · Molecular Cell · 31
PDF
Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
2018 · Gabrielle S. Wong, Jin Zhou, et al. · Nature Medicine · 12
PDF
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one
2016 · Andreas Lundqvist, Vincent van Hoef, et al. · Journal for ImmunoTherapy of Cancer · 12
PDF
Association of high TUBB3 with resistance to adjuvant docetaxel-based chemotherapy in gastric cancer: translational study of ITACA-S
2020 · Maria Di Bartolomeo, Alessandra Raimondi, et al. · Tumori Journal · 11
Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase
2018 · Sarit Schwartz, Chris Szeto, et al. · European Journal of Cancer · 11
PDF
Selecting patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of MGMT
2017 · Sarit Schwartz, Fabiola Cecchi, et al. · Annals of Oncology · 4
The prognostic role of microsatellite status, tumor mutational burden, and protein expression in CRC.
2018 · Sarit Schwartz, Yuan Tian, et al. · Journal of Clinical Oncology · 2
Abstract 735: HER2 protein quantification in multiple cancer indications identifies candidates for HER2 targeted therapies
2017 · Shankar Sellappan, Sarit Schwartz, et al. · Cancer Research · 1
Predicting survival in gastric cancer patients randomized to docetaxel with mass spectrometric quantitation of TUBB3
2017 · Fabiola Cecchi, Daniel Catenacci, et al. · Annals of Oncology · 1
Predicting survival in gastric cancer patients randomized to docetaxel with mass spectrometric quantitation of TUBB3.
2017 · Fabiola Cecchi, Daniel V.T. Catenacci, et al. · Journal of Clinical Oncology · 1
Selecting patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of MGMT.
2017 · Sarit Schwartz, Fabiola Cecchi, et al. · Journal of Clinical Oncology · 1
Abstract 4774: The antitumor effects of PI3K beta inhibitors in PTEN negative prostate cancer are enhanced by inhibition of reactivated PI3K alpha signaling
2014 · Sarit Schwartz, Brett S. Carver, et al. · Cancer Research · 1
Data from Application of a Translational Research Platform to Unveil Efficacy Signals and Mechanisms of Resistance of FGFR Inhibitors in Multiple FGFR-Altered Solid Tumors
2026 · Cinta Hierro, Mònica Sánchez-Guixé, et al.
Supplementary Data 1 from Application of a Translational Research Platform to Unveil Efficacy Signals and Mechanisms of Resistance of FGFR Inhibitors in Multiple FGFR-Altered Solid Tumors
2026 · Cinta Hierro, Mònica Sánchez-Guixé, et al.
Application of a Translational Research Platform to Unveil Efficacy Signals and Mechanisms of Resistance of FGFR Inhibitors in Multiple FGFR -Altered Solid Tumors
2026 · Cinta Hierro, Mònica Sánchez-Guixé, et al. · Clinical Cancer Research
Selecting patients with stage II/III colorectal cancer for 5-fluorouracil-based adjuvant chemotherapy using proteomic analysis.
2018 · Dongyao Yan, Ji Hyung Hong, et al. · Journal of Clinical Oncology
Abstract B200: Using “omics” to select immunotherapy and conventional therapy combinations
2018 · Sarit Schwartz, Robert Heaton, et al. · Molecular Cancer Therapeutics
Abstract 2666: Using “omics” to select immunotherapy and conventional therapy combinations
2017 · Sarit Schwartz, Robert Heaton, et al. · Cancer Research
Abstract 209: Proteomic analysis of therapeutic biomarkers in decalcified bone metastases
2017 · Fabiola Cecchi, Shankar Sellappan, et al. · Cancer Research
Abstract P1-17-02: Adaptive and acquired mechanisms of resistance to PI3K inhibitors
2015 · Sarat Chandarlapaty, Maurizio Scaltriti, et al. · Cancer Research
Abstract 5236: Novel network analysis framework identifies context-specific drug combinations in melanoma.
2013 · Oren Litvin, Sarit Schwartz, et al. · Cancer Research
Works count: 28
Citation count: 1,369
H-index: 9
I10-index: 9
Year
Topic
Type